Elizabeth Kiracofe, MD
Dermatology · Chicago, ILNPI 1336400217
Payments from drug & device makers
Across 1,880 payments — averaging $825.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$599K
- Regeneron Healthcare Solutions, Inc.$541K
- Arcutis Biotherapeutics, Inc.$222K
- UCB, Inc.$60K
- Incyte Corporation$40K
- Galderma Laboratories, L.p.$37K
- plus $54K from 26 others
What the payments were for
- Consulting fees$321,78121%
- Speaking & faculty fees$939,67761%
- Travel & lodging$256,27117%
- Food & beverage$34,7702%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 490 | $598,793 |
| Regeneron Healthcare Solutions, Inc. | 745 | $541,426 |
| Arcutis Biotherapeutics, Inc. | 233 | $222,009 |
| UCB, Inc. | 107 | $60,212 |
| Incyte Corporation | 63 | $39,850 |
| Galderma Laboratories, L.p. | 54 | $36,755 |
| Eli Lilly | 23 | $25,255 |
| Dermavant Sciences, Inc. | 8 | $9,496 |
| Johnson & Johnson | 7 | $6,037 |
| E.r. Squibb & Sons, L.L.C. | 14 | $4,374 |
| AbbVie(2 entities) | 21 | $3,740 |
| Lilly USA, LLC | 43 | $1,085 |
| Sanofi-aventis U.S. LLC | 15 | $780 |
| Pfizer | 27 | $778 |
| Kowa Pharmaceuticals America, Inc. | 1 | $750 |
| Journey Medical Corporation | 4 | $306 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $154 |
| LEO Pharma Inc. | 2 | $144 |
| EPI Health, LLC | 1 | $114 |
| Blueprint Medicines Corporation | 1 | $87 |
| Sun Pharmaceutical Industries Inc. | 4 | $84 |
| Prugen, Inc. Pharmaceuticals | 1 | $76 |
| Merz North America, Inc. | 2 | $64 |
| Novartis | 3 | $61 |
| Mayne Pharma Commercial LLC | 2 | $44 |
| Boehringer Ingelheim | 1 | $34 |
| Mission Pharmacal Company | 1 | $27 |
| Bristol Myers Squibb | 1 | $22 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
| Oxford Immunotec USA Inc | 1 | $17 |
| Almirall LLC | 1 | $15 |
| Organogenesis Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,552,620 in reported general payments places this provider in the 95th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $41,901 |
| Ketoconazole | 12 | $119 |
| Triamcinolone Acetonide | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Chicago
- Raj ChovatiyaChicago$3.7M
- Peter LioChicago$2.5M
- Walter LiszewskiChicago$1.2M
- Maria ColavincenzoChicago$627K
- Carolyn JacobChicago$606K
- Roopal KunduChicago$498K
- Sarah ChamlinChicago$415K
- Omer IbrahimChicago$313K
- Joaquin BrievaChicago$311K
- Caroline RobinsonChicago$308K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.